Capital Investment Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.68M Sell
3,780
-198
-5% -$88.2K 0.14% 161
2025
Q1
$1.93M Sell
3,978
-212
-5% -$103K 0.17% 137
2024
Q4
$1.69M Sell
4,190
-450
-10% -$181K 0.16% 139
2024
Q3
$2.16M Sell
4,640
-1,137
-20% -$529K 0.2% 116
2024
Q2
$2.71M Sell
5,777
-85
-1% -$39.8K 0.28% 82
2024
Q1
$2.45M Sell
5,862
-50
-0.8% -$20.9K 0.26% 88
2023
Q4
$2.41M Buy
5,912
+119
+2% +$48.4K 0.22% 82
2023
Q3
$2.01M Buy
5,793
+144
+3% +$50.1K 0.2% 92
2023
Q2
$1.99M Hold
5,649
0.2% 88
2023
Q1
$1.78M Buy
5,649
+6
+0.1% +$1.89K 0.21% 92
2022
Q4
$1.63M Sell
5,643
-33
-0.6% -$9.53K 0.19% 99
2022
Q3
$1.64M Sell
5,676
-55
-1% -$15.9K 0.21% 89
2022
Q2
$1.62M Sell
5,731
-305
-5% -$85.9K 0.2% 99
2022
Q1
$1.58M Sell
6,036
-7
-0.1% -$1.83K 0.17% 120
2021
Q4
$1.33M Sell
6,043
-420
-6% -$92.2K 0.16% 136
2021
Q3
$1.17M Buy
6,463
+300
+5% +$54.4K 0.15% 137
2021
Q2
$1.24M Sell
6,163
-160
-3% -$32.3K 0.16% 129
2021
Q1
$1.36M Buy
6,323
+100
+2% +$21.5K 0.19% 115
2020
Q4
$1.47M Buy
6,223
+3,160
+103% +$747K 0.22% 100
2020
Q3
$834K Sell
3,063
-817
-21% -$222K 0.16% 135
2020
Q2
$1.13M Sell
3,880
-75
-2% -$21.8K 0.23% 96
2020
Q1
$941K Buy
3,955
+80
+2% +$19K 0.23% 92
2019
Q4
$848K Buy
3,875
+437
+13% +$95.6K 0.23% 96
2019
Q3
$582K Sell
3,438
-50
-1% -$8.46K 0.16% 121
2019
Q2
$607K Sell
3,488
-1,107
-24% -$193K 0.18% 116
2019
Q1
$845K Sell
4,595
-626
-12% -$115K 0.31% 58
2018
Q4
$865K Sell
5,221
-114
-2% -$18.9K 0.37% 54
2018
Q3
$1.03M Sell
5,335
-5
-0.1% -$963 0.48% 50
2018
Q2
$908K Hold
5,340
0.45% 54
2018
Q1
$870K Sell
5,340
-225
-4% -$36.7K 0.49% 46
2017
Q4
$834K Sell
5,565
-23
-0.4% -$3.45K 0.49% 44
2017
Q3
$850K Sell
5,588
-675
-11% -$103K 0.52% 42
2017
Q2
$807K Sell
6,263
-200
-3% -$25.8K 0.53% 46
2017
Q1
$707K Buy
6,463
+25
+0.4% +$2.74K 0.52% 55
2016
Q4
$474K Buy
+6,438
New +$474K 0.41% 63